These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4740461)

  • 1. Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.
    Nelson DA; Vates TS; Thomas RB
    Acta Neurol Scand; 1973; 49(2):176-88. PubMed ID: 4740461
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating.
    Baker AG
    Ann Allergy; 1967 Dec; 25(12):665-72. PubMed ID: 6072742
    [No Abstract]   [Full Text] [Related]  

  • 3. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces.
    Abel R; Nelson DA; Bernat JL
    Del Med J; 1977 Jun; 49(6):331-43. PubMed ID: 577483
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrathecal methylprednisolone for postherpetic neuralgia.
    Nelson DA; Landau WM
    N Engl J Med; 2001 Mar; 344(13):1019; author reply 1021-2. PubMed ID: 11280320
    [No Abstract]   [Full Text] [Related]  

  • 5. Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis.
    Bernat JL; Sadowsky CH; Vincent FM; Nordgren RE; Margolis G
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1124-8. PubMed ID: 1037000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
    Jedlicka P; Kupka J; Kocinová F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical meningitis related to intrathecal corticosteroid therapy.
    Plumb VJ; Dismukes WE
    South Med J; 1977 Oct; 70(10):1241-3. PubMed ID: 578589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.
    Goldstein NP; McGuckin WF; McKenzie BF; Mattox VR
    Trans Am Neurol Assoc; 1970; 95():243-4. PubMed ID: 5537958
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal Depo-Medrol: a literature review.
    Wilkinson HA
    Clin J Pain; 1992 Mar; 8(1):49-56; discussion 57-8. PubMed ID: 1533555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
    Sbarbaro V; Girelli Bruni E; Monaco V; Gasperini GF; Zardini GB; Brogi L
    Minerva Med; 1974 Sep; 65(65):3407-11. PubMed ID: 4479023
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraspinal steroid therapy.
    Bernat JL
    Neurology; 1981 Feb; 31(2):168-71. PubMed ID: 7007914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methylprednisolone acetate in intrathecal administration in multiple sclerosis].
    Palchetti R; Giunta A; Tortoli V; Scarpelli PT
    Rass Neurol Veg; 1965 Jun; 19(3):243-8. PubMed ID: 5899668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lumbar intrathecal injection of methylprednisolone acetate in the treatment of multiple sclerosis].
    Delzanno GB; Jann G
    Clin Ter; 1969 Jan; 48(2):151-5. PubMed ID: 5409031
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.
    Rocchelli B; Poloni M; Mazzarello P; Piccolo G; Delodovici M; Pinelli P
    Ital J Neurol Sci; 1982 Jul; 3(2):119-26. PubMed ID: 6896866
    [No Abstract]   [Full Text] [Related]  

  • 15. An attempt to develop a model to study the effects of intrathecal steroids.
    Swai EA; Rosen M
    Eur J Anaesthesiol; 1986 Mar; 3(2):127-36. PubMed ID: 3536491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
    Hrazdira CL; Mandzjuk B; Skálová M
    Cesk Neurol Neurochir; 1974 Sep; 37(5):293-300. PubMed ID: 4479029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations on intrathecal administration of corticosteroids in case of multiple sclerosis].
    Cendrowski W
    Wiad Lek; 1976 Feb; 29(3):193-6. PubMed ID: 946336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].
    Heun R; Emser W; Schimrigk K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Jun; 20(2):88-91. PubMed ID: 2503359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis.
    Nelson D
    Arch Neurol; 1976 May; 33(5):373. PubMed ID: 946766
    [No Abstract]   [Full Text] [Related]  

  • 20. Dangers from methylprednisolone acetate therapy by intraspinal injection.
    Nelson DA
    Arch Neurol; 1988 Jul; 45(7):804-6. PubMed ID: 3291836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.